Rhode Island bills · 2026 Regular Session
Rhode Island HB 7187
AN ACT RELATING TO INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION REVIEW ACT
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Casimiro
- Fogarty (Democratic)
- Carson (Democratic)
- Potter (Democratic)
- Bennett (Democratic)
- Edwards (Democratic)
Summary
Official abstract published by the Rhode Island legislature· summary
Prohibits healthcare insurers from requiring or conducting a review for prescription medicine used to treat alcohol or opioid use disorder containing Methadone, Burenorphine, or Naltrexone, or approved to mitigate opioid withdrawal symptoms.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Feb 3, 2026 · Legislature
02/03/2026 Committee recommended measure be held for further study - Jan 30, 2026 · Legislature
01/30/2026 Scheduled for hearing and/or consideration (02/03/2026) - Jan 21, 2026 · House
01/21/2026 Introduced, referred to House Health & Human Services